STEVE ASELAGE - 14 Jan 2022 Form 4 Insider Report for Acer Therapeutics Inc.

Role
Director
Signature
/s/ Harry S. Palmin, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
14 Jan 2022
Net transactions value
$0
Form type
4
Filing time
19 Jan 2022, 15:15:05 UTC
Previous filing
13 Dec 2021
Next filing
02 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACER Stock Option (right to buy) Award $0 +18,500 $0.000000 18,500 14 Jan 2022 Common Stock 18,500 $2.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in full on January 14, 2023.